ArticleClinical immunology (Orlando, Fla.)2013
Medulloblastoma expresses CD1d and can be targeted for immunotherapy with NKT cells.
Daofeng Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
49 papers cite it
this papercites it